Company / Total Assets
BioLife Solutions, Inc. Total Assets History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Assets
$405.9M
FY2025
5-year range
$399.5M / $554.3M
FY2021-FY2025
Trend
+1.6%
vs FY2024
Sector context
#148 of 166
Health Care
What the data says
BioLife Solutions, Inc.'s total assets of $406M is lower than 89% of companies in the Health Care sector (FY2025). Total Assets returned to growth in FY2025 after 3 years of decline, reaching $406M.
Based on SEC 10-K filings.
$406M in FY2025 with a 5-year CAGR of +11.6%.
Remained stable around $406M over the past 2 years.
Health Care sector context is included.
Total Assets over time
Growth rates
- 3-Year CAGR
- -3.4%
- 5-Year CAGR
- +11.6%
- 10-Year CAGR
- -
Sector benchmark
Bottom 11% in Health CareTop 89% of 166This company $405.9M Sector average $14.9B
▼
-97.3% below sector average
Key checks
Key Insights
- 5-year CAGR of +11.6%, indicating consistent growth.
- In FY2025, total assets increased 1.6% year-over-year.
- Ranks #148 out of 166 companies in the Health Care sector.
- Peak total assets was recorded in FY2021.
Company context
Key Data Points
- Altman Z-Score 4.67 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $405.9M | +1.6% |
| FY2024 | $399.5M | -3.2% |
| FY2023 | $412.7M | -8.3% |
| FY2022 | $450.2M | -18.8% |
| FY2021 | $554.3M | +136.0% |
| FY2020 | $234.8M | +153.0% |
| FY2019 | $92.8M | +655.0% |
| FY2018 | $12.3M | +1.2% |
| FY2017 | $12.1M | +53.2% |
| FY2016 | $7.9M | -35.9% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026